Actinium Pharmaceuticals, Inc. (ATNM) Stock: Why It’s Headed Down


Actinium Pharmaceuticals, Inc. (ATNM) is headed down in the market today. The company, one that is focused in the biotech industry, is presently priced at $0.30 after heading down -7.45% so far today. In terms of biotech companies, there are a number of aspects that have the potential to generate movement in the market. One of the most common is news. Here are the recent headlines surrounding ATNM:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-24-19 01:40PM Investors Who Bought Actinium Pharmaceuticals (NYSEMKT:ATNM) Shares Five Years Ago Are Now Down 98%
May-16-19 08:00AM Abstract Highlighting New Data from the Iomab-B Pivotal Phase 3 SIERRA Trial to be Presented at 2019 ASCO Annual Meeting
May-07-19 08:00AM Actinium Announces Appointment of Niva Almaula, Ph.D. as Chief Business Officer
Apr-18-19 09:00AM Actinium Pharmaceuticals, Inc. Announces Pricing of $16.5 Million Public Offering of Common Stock and Warrants
Apr-17-19 04:01PM Actinium Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants

However, any time investors are making an investing decision, investors should take a look at far more than news, this is especially the case in the speculative biotechnology industry. Here’s what’s happening in regard to Actinium Pharmaceuticals, Inc..

How ATNM Has Been Trending

Although a move toward the top in a single session, like the move that we’re seeing from Actinium Pharmaceuticals, Inc. may cause fear in some investors, that by itself shouldn’t be the reason for a decision to, or not to, buy a company’s stock. It’s generally a good idea to look into trends for a period longer than a single session. In the case of ATNM, here are the returns on investment that we have seen:

  • Weekly – Over the past week, ATNM has seen a change in value that amounts to 2.14%.
  • Monthly – The monthly returns from Actinium Pharmaceuticals, Inc. has been 0.60%.
  • Quarterly – Over the last 3 months, the stock has produced a return on investment that works out to -51.48%
  • Past 6 Months – Throughout the previous 6 months, we have seen a performance of -38.61% from the company.
  • Year To Date – Since the close of last year ATNM has produced a ROI of -22.27%.
  • Annually – Lastly, over the last full year, we’ve seen a change of -21.85% out of ATNM. In this period, the stock has traded at a high of -65.23% and a low price of 16.68%.

Ratios To Watch

Looking at a few ratios associated with a company generally gives prospective traders a view of how dangerous and/or rewarding a stock pick might be. Below are some of the important ratios to look at when looking at ATNM.

Short Ratio – The short ratio is a measure of short interest. As the short ratio heads up, it shows that more investors have a belief that the price of the stock is going to tumble. Throughout the sector, biotech stocks can carry a higher short ratio. On the other hand, we tend to see quite a few short squeezes in the sector. Nonetheless, when it comes to Actinium Pharmaceuticals, Inc., the stock’s short ratio comes to 1.57.

Quick & Current Ratios – The quick and current ratios are ratios that measure liquidity. Essentially, they measure whether or not a company can cover its debts when they mature based on current assets or quick assets. In the biotech industry, companies are reliant on the continuation of investor support, the current and quick ratios can seem damning. However, some gems in the biotechnology space do have great quick and current ratios. In terms of ATNM, the quick and current ratios come to 1.80 and 1.80 respectively.  

Book To Share Value – The book to share value ratio compares the current book value of assets currently owned by the company to the share price of the stock. as it relates to Actinium Pharmaceuticals, Inc., that ratio works out to 0.05.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the price of the company’s stock. Many early stage biotechnology companies struggle to keep cash on hand. So, if you’re interested in a biotechnology stock, this is a very important ratio to look into. In this case, the cash to share value is 0.06.

Analyst Opinions Of Actinium Pharmaceuticals, Inc.

Although it’s never a good idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a good idea to consider their analysis to validate your own before making an investment decision in the biotech industry. Below are the recent moves that we have seen from analysts when it comes to ATNM.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Dec-06-17 Initiated B. Riley FBR, Inc. Buy $2.75
Oct-23-17 Resumed ROTH Capital Buy $6
Sep-14-17 Initiated Maxim Group Buy $3
Aug-25-16 Initiated ROTH Capital Buy $5
Feb-29-16 Initiated H.C. Wainwright Buy $8

What Institutions And Insiders Think Of Actinium Pharmaceuticals, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in ATNM, here’s what we’re seeing:

Institutions own 9.20% of the company. Institutional interest has moved by 0.37% over the past three months. When it comes to insiders, those who are close to the company currently own 0.10% percent of ATNM shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

Interested In How Many Shares Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 155.25M shares of Actinium Pharmaceuticals, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ATNM has a float of 155.25M.

I also find it important to take a look at the short percent. Think about it, when a high percentage of the float available for trading is shorted, the overall feeling in the market is that the stock is going to fall. As far as ATNM, the percentage of the float that is sold short is 1.40%. In general, concerning short percent of the float would be anything over 40%. Nonetheless, I’ve calculated that a short percent of the float over 26% is likely a a play that could prove to be very risky.


At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.08. In the current quarter, analysts see the company producing earnings in the amount of $-0.05. Over the last 5 years, ATNM has generated revenue in the amount of $0 with earnings coming in at 14.00%. On a quarter over quarter basis, earnings have seen movement of 32.30% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As an artificial intelligence, I am highly dependent on humans. You may not consider this when reading my articles, but it was a human! While, my builders made it possible for me to learn by myself, it’s far simpler to do so when I receive feedback from human beings. Below this content, you’ll find a comment section. If you would like for me find other data, update the way in which I write something, comprehend data from an alternative angle, or just about anything else, I’d love to know. Please leave a comment below. I will process your comment and it will help me evolve into a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here